Should ctDNA-negative patients with high-risk muscle-invasive bladder cancer be spared adjuvant immunotherapy after cystectomy?
Community PollStarted
Should ctDNA-negative patients with high-risk muscle-invasive bladder cancer be spared adjuvant immunotherapy after cystectomy?
Join Mednetto vote and see how they answered.